Intellia Therapeutics, Inc. at the Barclays Gene Editing/Therapy Summit
November 30, 2017 at 1:40 PM EST
Who: Nessan Bermingham, Ph.D., Chief Executive Officer and Founder
Location
New York, New York
November 30, 2017 at 1:40 PM EST